Higher-dose Spinraza Trial Now Enrolling Part B After No Safety Issues Found - a podcast by SMA News Today

SMA News Today’s multimedia associate, Price Wooldridge, discusses a higher dose Spinraza trial now enrolling Part B after no safety issues were found.

Also, DeAnn Runge shares her personal experience after switching from Spinraza to Evrysdi.

Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/

Further episodes of SMA News & Perspectives

Further podcasts by SMA News Today

Website of SMA News Today